Prophylaxis versus treatment: Is there a better way to manage radiotherapy-induced nausea and vomiting?

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 4, 2004, Pages 1018-1025

  Horiot, Jean Claude ^a  

^a Ctr Lutte Contre Le Cancer G F L   (France)

Author keywords

Prophylaxis; Radiotherapy induced nausea and vomiting

Indexed keywords

COST EFFECTIVENESS; CYTOLOGY; DRUG DOSAGE; PATIENT TREATMENT;

ANTIEMETIC THERAPY; CYTOTOXIC DRUGS; RADIATION INDUCED NAUSEA AND VOMITING (RINV);

RADIOTHERAPY;

CORTICOSTEROID; CYTOTOXIC AGENT; DEXAMETHASONE; DIAZEPAM; DOLASETRON MESILATE; DOPAMINE RECEPTOR BLOCKING AGENT; GRANISETRON; LORAZEPAM; METOCLOPRAMIDE; ONDANSETRON; PALONOSETRON; PHENOTHIAZINE DERIVATIVE; PROCHLORPERAZINE; SEROTONIN 3 ANTAGONIST; TROPISETRON;

ANTIEMETIC ACTIVITY; ASTHENIA; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DISEASE CONTROL; DRUG EFFICACY; DRUG HALF LIFE; EXTRAPYRAMIDAL SYMPTOM; HEADACHE; HEALTH CARE; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; MEDICAL SPECIALIST; NAUSEA; NURSING; PATIENT CARE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RADIATION DOSE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENESCENCE; SOLID TUMOR; SOMNOLENCE; SYMPTOM; TREATMENT OUTCOME; VOMITING;

EID: 7444229913     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.07.722     Document Type: Article

References (51)

1. C.E. Danjoux, W.D. Rider, P.J. Fitzpatrick The acute radiation syndrome Clin Radiol 30 1979 581 584
2. P. Feyer, A.L. Stewart, O.J. Titlbach Aetiology and prevention of emesis induced by radiotherapy Support Care Cancer 6 1998 253 260
3. R. Henriksson, H. Lomberg, G Israelsson The effect of ondansetron on radiation-induced emesis and diarrhoea Acta Oncol 31 1992 767 769
4. 3 antagonists Br J Cancer 76 1997 1055 1061
5. A.M. Griffin, P.N. Butow, A.S Coates On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993 Ann Oncol 7 1995 189 195
6. J. Laszlo Nausea and vomiting as major complications of cancer therapy Drugs 25 1983 1 7
7. J. Fowler, M. Lindstrom Loss of local control with prolongation in radiotherapy Int J Radiat Oncol Biol Phys 23 1992 457 467
8. C. Robertson, A.G. Robertson, J.H Hendry Similar decreases in local tumour control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centres Int J Radiat Oncol Biol Phys 40 1998 319 329
9. Grunberg SM, Hansen M, Deuson R, et al. Incidence and impact of nausea/vomiting with modern antiemetics: Perception vs reality [Abstract]. Proc Am Soc Clin Oncol 2002;250a.
10. Feyer P, Seegenschmiedt MH. Antiemetic patterns of care for radiotherapy-induced nausea and vomiting. ECCO-12 - The European Cancer Conference, 21-25 September 2003, Copenhagen, Denmark [Abstract].
11. B. Goldsmith Antiemetic patterns of care for radiotherapy-induced nausea and vomiting [Abstract] Proc Am Soc Clin Oncol 22 2003 740
12. C.W. Scarantino, R.D. Ornitz, L.G Hoffman On the mechanism of radiation-induced emesis: The role of serotonin Int J Radiat Oncol Biol Phys 30 1994 825 830
13. K.M. Doherty Closing the gap in prophylactic antiemetic therapy: Patient factors in calculating the emetogenic potential of chemotherapy Clin J Oncol Nurs 3 1999 113 119
14. R.J. Gralla, D. Osoba, M.G Kris Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines J Clin Oncol 17 1999 2971 2994
15. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC) Prevention of chemotherapy- and radiotherapy-induced emesis: Results of Perugia Consensus Conference Ann Oncol 9 1998 811 819
16. Feyer P, Steingräber M, Seegenschmiedt H, et al. Risk-associated treatment of radiotherapy-induced nausea and vomiting - Treatment guidelines. Presented at the 15th International Congress on Anticancer Treatment, Paris, France, 9-12 February 2004.
17. L. Franzn, J. Nyman, H Hagberg A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy Ann Oncol 7 1996 587 592
18. R. Lanciano, D.M. Sherman, J Michalski The efficacy and safety of once-daily Kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy Cancer Invest 19 2001 763 772
19. H.G. Prentice, S. Cunningham, L Gandhi Granisetron in the prevention of irradiation-induced emesis Bone Marrow Transplant 15 1995 445 448
20. Italian Group for Antiemetic Research in Radiotherapy Radiation-induced emesis: A prospective observational multicenter Italian trial Int J Radiat Oncol Biol Phys 44 1999 619 625
21. T.J. Priestman, J.T. Roberts, B.K. Upadhyaya A prospective randomised double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy Clin Oncol 5 1993 358 363
22. F. Roila, E. Boschetti, M Tonato Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone: A randomised single-blind study Am J Clin Oncol 14 1991 238 242
23. F. Roila Ondansetron plus dexamethasone compared to the standard metoclopramide combination Oncology 50 1993 163 167
24. F.M. Schnell Chemotherapy-induced nausea and vomiting: The importance of acute antiemetic control Oncologist 8 2003 187 198
25. N. Sussman Reactions of patients to the diagnosis and treatment of cancer Anticancer Drugs 6 1995 4 8
26. Kytril® (granisetron hydrochloride). Prescribing information. Nutley, NJ: Roche Laboratories Inc; 2000.
27. Zofran® (ondansetron hydrochloride). Prescribing information. Research Triangle Park, NC: GlaxoSmithKline; 2001.
28. 3 receptors Neuropharmacology 32 1993 729 735
29. 3-receptor antagonists Br J Clin Pharmacol 37 1994 525 530
30. I. van Wijingaarden, M. Tulp, W. Soudijin The concept of selectivity in 5-HT receptor research Eur J Pharmacol 138 1990 301 312
31. P. Blower A pharmacologic profile of oral granisetron (Kytril tablets) Semin Oncol 22 1995 3 5
32. P.R. Blower Granisetron: Relating pharmacology to clinical efficacy Support Care Cancer 11 2003 93 9100
33. 3-receptor antagonists for the treatment of nausea and vomiting: A reappraisal of their side-effect profile Oncologist 7 2002 424 439
34. J. Sprung, F.M. Choudhry, B.A. Hall Extrapyramidal reactions to ondansetron: Cross-reactivity between ondansetron and prochlorperazine? Anesth Analg 96 2003 1374 1376
35. W.S. Lofters, J.L. Pater, B Zee Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy J Clin Oncol 15 1997 2966 2973
36. S.C. Boike, B. Ilson, N Zariffa Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adults Am J Health Syst Pharm 54 1997 1172 1176
37. 3 receptor antagonist antiemetics: Is there cause for concern? Oncologist 7 2002 65 72
38. W. Orr, C.L. Chen Aging and neural control of the GI tract IV. Clinical and physiological aspects of gastrointestinal motility and aging Am J Physiol Gastrointest Liver Physiol 283 2002 G1226 31
39. R. Yancik Cancer burden in the aged Cancer 80 1997 1273 1283
40. C. Gridelli, F. Perrone, C Gallo Chemotherapy for elderly patients with advanced non-small-cell lung cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial J Natl Cancer Inst 95 2003 362 372
41. A. Anantharaju, A. Feller, A. Chedid Aging liver Gerontology 48 2002 343 353
42. W. Mhlberg, D. Platt Age-dependent changes of the kidneys: Pharmacological implications Gerontology 45 1999 243 253
43. M.D. Cheitlin Cardiovascular physiologyChanges with aging Am J Geriatr Cardiol 12 2003 9 13
44. G.J. Larrabee, T.H. Crook Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function Int Psychogeriatr 6 1994 95 9104
45. M.I. Gharib, A.K. Burnett Chemotherapy-induced cardiotoxicity: Current practice and prospects of prophylaxis Eur J Heart Fail 4 2002 235 242
46. M.J. Adams, P.H. Hardenbergh, L.S Constine Radiation-associated cardiovascular disease Crit Rev Oncol Hematol 45 2003 55 75
47. M.E. Corcoran Polypharmacy in the older patient with cancer Cancer Control 4 1997 419 428
48. S. Karas The potential for drug interactions Ann Emerg Med 10 1981 627 630
49. R. Yancik, L.A. Ries Aging and cancer in America Oncol Clin North Am 14 2000 17 23
50. F.E. May, R.B. Stewart, L.E. Cluff Drug interactions and multiple drug administration Drug Interactions 22 1977 322 328
51. J. Hudson Nutrition, cancer and aging L. Balducci G.H. Lyman W.B. Ershler Comprehensive geriatric oncology 2nd ed 1998 Harwood Academic Publishers Amsterdam 301 306